Pivotal Therapeutics Inc.
Pivotal Therapeutics Inc.
Indice CSE:
Devise:
Pivotal Therapeutics Inc. is a specialty pharmaceutical company with a focus on Omega-3 therapies for cardiovascular disease (CVD) and overall health. The company currently has two commercial products: VASCAZEN® is available in the US by prescription only and OMAZEN™ is available for sale as a natural health product in Canada.The company's lead product VASCAZEN® is a prescription only Medical Food for the treatment of an Omega-3 Deficiency (OM3D) in patients with cardiovascular disease. The company's second product OMAZEN® is an ultra pure Omega-3 for the maintenance of good health.
Pivotal Therapeutics Inc. (PVO)
SEDAR Information
Information d'entreprise
Addresse
81 Zenway Blvd Unit 10
Woodbridge, ON L4H 0S5
CanadaTéléphone
1-905-8569797Fax
1-905-8562177Courriel
EBortoluzzi@pivotaltherapeutics.usURL
http://www.pivotaltherapeutics.usDate d’inscription à la cote
Jeudi, mai 19, 2011Relations avec les investisseurs
Pivotal Therapeutics Inc.Vérificateur
MNP LLP.Capitalisation
Capitalisation:
96566669Réservé à l'émission:
10680384Bulletins
09/06/2011
2011-0601 (PVO) Appointment of Market Maker
June 9, 2011
PI Financial Corp. has been approved to act as market maker on symbol PVO, effective immediately.
